论文部分内容阅读
目的研究并分析治疗急性心肌梗死室性心律失常患者时使用门冬氨酸钾镁与胺碘酮联合治疗的效果。方法收集急性心肌梗死室性心律失常患者共122例,按照随机数字表将其分为对照组(61例)和观察组(61例),对照组的治疗药物为胺碘酮,观察组联合门冬氨酸钾镁,将两组临床疗效进行观察和对比。结果观察组的总有效率为95.08%,显著高于对照组的80.33%,x~2=6.157,P=0.013。结论在急性心肌梗死室性心律失常患者的治疗过程中,门冬氨酸钾镁与胺碘酮联合治疗能够显著提升治愈率,缓解患者痛苦,值得推广应用。
Objective To study and analyze the effect of combined use of potassium-magnesium aspartate and amiodarone in the treatment of ventricular arrhythmias in patients with acute myocardial infarction. Methods A total of 122 patients with ventricular arrhythmia were collected and divided into control group (61 cases) and observation group (61 cases) according to random number table. The control group was treated with amiodarone and observation group Magnesium aspartate, the clinical efficacy of the two groups were observed and compared. Results The total effective rate in the observation group was 95.08%, significantly higher than that in the control group (80.33%, x ~ 2 = 6.157, P = 0.013). Conclusions In the course of treatment of patients with ventricular arrhythmia due to acute myocardial infarction, the combined treatment of potassium-magnesium aspartate and amiodarone can significantly improve the cure rate and alleviate the suffering of patients, which is worth popularizing and applying.